Ineos Styrolution presents two new styrenics grades at Pharmapack 2017, Paris
INEOS Styrolution, the global player in styrenics, has announced two new styrenics grades, both of which designed for very specific use by medical device manufacturers.
Pharmaceuticals, Biotechnology and Life Sciences
INEOS Styrolution, the global player in styrenics, has announced two new styrenics grades, both of which designed for very specific use by medical device manufacturers.
Pharmapack 2017, kicking off on February 1, 2017 marks 20 years of Pharmapack. We talked with Anne Schumacher, Brand Director at Pharmapack Europe.
Allergy Therapeutics, a pharmaceutical company specialising in allergy vaccines, has announced positive results from preclinical research of its therapeutic peanut allergy vaccine, Polyvac Peanut.
Sanofi announced on Wednesday two approvals for its drugs in North America. Rheumatoid arthritis drug, which it has made in cooperation with Regeneron Pharmaceuticals, has been approved by Health Canada and the U.S. Food and Drug Administration (FDA) has approved Xyzal Allergy 24HR
Several leaders of some of the largest pharmaceutical companies have met on Tuesday with the newly elected US president, Donald Trump to discuss industry related topics, agreeing that the talks were positive.
Akers Biosciences, a developer of rapid health information technologies, expects the total revenue for the 2016 year to be about…
A drug widely used to cure malaria has failed for the first time in patients being treated in Britain, raising questions over whether the parasite is becoming resistant to drugs, researchers said on Tuesday
U.S. President Donald Trump in a meeting on Tuesday with pharmaceutical executives called on them to manufacture more of their drugs in the United States and cut prices, while vowing to speed approval of new medicines and ease regulation.
The newly appointed president of the United States of America, Donald Trump said that he wants pharmaceutical companies to manufacture their products in America, during the meeting he held with leaders of some of the major drugmakers.
Driven by new products, including Trulicity, Cyramza, Jardiance and Taltz, Lilly’s volume-driven significant growth in 2016.